Alterations of VIII von Willebrand factor in clinical conditions associated with an increase in its plasma concentration

R. Lombardi, P. M. Mannucci, M. J. Seghatchian

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Factor VIII-related antigen (VIIIR:Ag) was consistently higher than factor-VIII procoagulant activity (VIII:C) in 57 patients with clinical conditions characterized by acute-phase reactions. Two different methods for measuring VIII:C ( one- and two-stage assays) and VIIIR:Ag (electroimmunodiffusion and immunoradiometric assay) gave concordant results in the majority of cases. In 43% of plasma samples, crossed immunoelectrophoresis in agarose gel was characterized by the appearance of an additional, fast-moving precipitin peak which was immunologically identical with the major, slower-moving VIIIR:Ag peak. The fast-moving peak was detected in all the patients with clinical conditions typically associated with plasma proteolysis (DIC, acute pancreatitis, during thrombolytic therapy). It was present in a smaller proportion of cases with liver and renal failure and malignancies and in the post-operative period. The additional VIIIR:Ag peak is thought to be the result of in vivo factor VIII/von Willebrand factor fragmentation by proteolytic enzymes.

Original languageEnglish
Pages (from-to)61-68
Number of pages8
JournalBritish Journal of Haematology
Volume49
Issue number1
Publication statusPublished - 1981

Fingerprint

von Willebrand Factor
Antigens
Two-Dimensional Immunoelectrophoresis
Immunoradiometric Assay
Precipitins
Dacarbazine
Acute-Phase Reaction
Thrombolytic Therapy
Liver Failure
Factor VIII
Pancreatitis
Sepharose
Proteolysis
Renal Insufficiency
Peptide Hydrolases
Gels
Neoplasms

ASJC Scopus subject areas

  • Hematology

Cite this

Alterations of VIII von Willebrand factor in clinical conditions associated with an increase in its plasma concentration. / Lombardi, R.; Mannucci, P. M.; Seghatchian, M. J.

In: British Journal of Haematology, Vol. 49, No. 1, 1981, p. 61-68.

Research output: Contribution to journalArticle

@article{cd7a39b71dac4a52be821a4b50f6188f,
title = "Alterations of VIII von Willebrand factor in clinical conditions associated with an increase in its plasma concentration",
abstract = "Factor VIII-related antigen (VIIIR:Ag) was consistently higher than factor-VIII procoagulant activity (VIII:C) in 57 patients with clinical conditions characterized by acute-phase reactions. Two different methods for measuring VIII:C ( one- and two-stage assays) and VIIIR:Ag (electroimmunodiffusion and immunoradiometric assay) gave concordant results in the majority of cases. In 43{\%} of plasma samples, crossed immunoelectrophoresis in agarose gel was characterized by the appearance of an additional, fast-moving precipitin peak which was immunologically identical with the major, slower-moving VIIIR:Ag peak. The fast-moving peak was detected in all the patients with clinical conditions typically associated with plasma proteolysis (DIC, acute pancreatitis, during thrombolytic therapy). It was present in a smaller proportion of cases with liver and renal failure and malignancies and in the post-operative period. The additional VIIIR:Ag peak is thought to be the result of in vivo factor VIII/von Willebrand factor fragmentation by proteolytic enzymes.",
author = "R. Lombardi and Mannucci, {P. M.} and Seghatchian, {M. J.}",
year = "1981",
language = "English",
volume = "49",
pages = "61--68",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley & Sons, Ltd (10.1111)",
number = "1",

}

TY - JOUR

T1 - Alterations of VIII von Willebrand factor in clinical conditions associated with an increase in its plasma concentration

AU - Lombardi, R.

AU - Mannucci, P. M.

AU - Seghatchian, M. J.

PY - 1981

Y1 - 1981

N2 - Factor VIII-related antigen (VIIIR:Ag) was consistently higher than factor-VIII procoagulant activity (VIII:C) in 57 patients with clinical conditions characterized by acute-phase reactions. Two different methods for measuring VIII:C ( one- and two-stage assays) and VIIIR:Ag (electroimmunodiffusion and immunoradiometric assay) gave concordant results in the majority of cases. In 43% of plasma samples, crossed immunoelectrophoresis in agarose gel was characterized by the appearance of an additional, fast-moving precipitin peak which was immunologically identical with the major, slower-moving VIIIR:Ag peak. The fast-moving peak was detected in all the patients with clinical conditions typically associated with plasma proteolysis (DIC, acute pancreatitis, during thrombolytic therapy). It was present in a smaller proportion of cases with liver and renal failure and malignancies and in the post-operative period. The additional VIIIR:Ag peak is thought to be the result of in vivo factor VIII/von Willebrand factor fragmentation by proteolytic enzymes.

AB - Factor VIII-related antigen (VIIIR:Ag) was consistently higher than factor-VIII procoagulant activity (VIII:C) in 57 patients with clinical conditions characterized by acute-phase reactions. Two different methods for measuring VIII:C ( one- and two-stage assays) and VIIIR:Ag (electroimmunodiffusion and immunoradiometric assay) gave concordant results in the majority of cases. In 43% of plasma samples, crossed immunoelectrophoresis in agarose gel was characterized by the appearance of an additional, fast-moving precipitin peak which was immunologically identical with the major, slower-moving VIIIR:Ag peak. The fast-moving peak was detected in all the patients with clinical conditions typically associated with plasma proteolysis (DIC, acute pancreatitis, during thrombolytic therapy). It was present in a smaller proportion of cases with liver and renal failure and malignancies and in the post-operative period. The additional VIIIR:Ag peak is thought to be the result of in vivo factor VIII/von Willebrand factor fragmentation by proteolytic enzymes.

UR - http://www.scopus.com/inward/record.url?scp=0019391551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019391551&partnerID=8YFLogxK

M3 - Article

VL - 49

SP - 61

EP - 68

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 1

ER -